Why Is Telix Pharma Stock Soaring Tuesday?

Telix Pharmaceuticals Limited (NASDAQ:TLX) shares climbed Tuesday after the company reported solid revenue growth and continued progress across its therapeutics pipeline. Wedbush analyst David Nierengarten reiterated an Outperform rating on the stock and maintained a...

Spectral Capital Announces Full-Year 2025 Results

– Company on Track to Meet or Exceed 2026 Revenue Guidance of $450 Million with Full-Year Profitability – SEATTLE, April 7, 2026 /PRNewswire/ — Spectral Capital Corporation (OTCQB:FCCN) (“Spectral” or the “Company”), a...